Stock Market Reviews

APLT (Applied Therapeutics, Inc.) News

Get the latest news, insights, and market updates on APLT (Applied Therapeutics, Inc.). Explore the news page 2 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.

• Applied Therapeutics Reports Fourth Quarter and Year-end 2024 Financial Results
  - Appointed John H. Johnson as Executive Chairman; Todd F. Baumgartner, MD, MPH as Chief Regulatory Officer; and Reena Thomas Colacot as Vice President and Head of Quality NEW YORK, April 14, 2025 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT) (the “Company”), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today reported financial results for the fourth quarter
  Apr 14, 2025 - $APLT
• Applied Therapeutics Files Form 12b-25 with the Securities and Exchange Commission
  NEW YORK, March 31, 2025 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT) (the “Company”), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced that it has filed a Form 12b-25, Notification of Late Filing, with the U.S. Securities and Exchange Commission (“SEC”) related to the Company’s Annual Report on Form 10-K for the fiscal year 2024 (the “Form 10-K
  Mar 31, 2025 - $APLT
• Applied Therapeutics Appoints Todd F. Baumgartner, MD, MPH as Chief Regulatory Officer
  Dr. Baumgartner will advance Applied’s preparation for upcoming regulatory interactionsNEW YORK, March 19, 2025 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a biopharmaceutical company dedicated to creating transformative treatments for rare disease, today announced the appointment of Todd F. Baumgartner, MD, MPH as Chief Regulatory Officer. Dr. Baumgartner will serve as part of the Company’s executive leadership team and will be responsible for leading Applied’s global regulat
  Mar 19, 2025 - $APLT
• 3 Penny Stocks With At Least $50M Market Cap
  The U.S. stock market has recently seen a rebound, buoyed by an encouraging Consumer Price Index report that suggests potential adjustments in Federal Reserve policies. For investors seeking opportunities beyond the well-known giants, penny stocks—typically smaller or newer companies—can present intriguing possibilities despite their somewhat outdated label. This article explores three penny stocks that showcase financial strength and potential for growth, offering investors a chance to...
  Mar 12, 2025 - $APLT
• Why pharma is still far from a treatment for galactosemia
  With issues in therapy delivery and a barren trial landscape, short-term chances for a commercial galactosemia treatment are low.
  Feb 28, 2025 - $APLT
• BeiGene (ONC) Soars 3.2%: Is Further Upside Left in the Stock?
  BeiGene (ONC) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
  Feb 21, 2025 - $APLT
• Applied Therapeutics Appoints Reena Thomas Colacot as Vice President and Head of Quality
  Ms. Colacot brings over 25 years of quality leadership experience across the biopharmaceutical and medical device industriesNEW YORK, Jan. 21, 2025 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a biopharmaceutical company dedicated to creating transformative treatments for rare disease, today announced the appointment of Reena Thomas Colacot as Vice President and Head of Quality. Ms. Colacot joins Applied with over 25 years of quality leadership experience across the biopharmace
  Jan 21, 2025 - $APLT
• Is Applied Therapeutics (APLT) the Best Penny Stock to Invest In According to Media?
  We recently compiled a list of the 12 Best Penny Stocks to Invest in According to the Media. In this article, we are going to take a look at where Applied Therapeutics, Inc. (NASDAQ:APLT) stands against other penny stocks to buy according to the media. Small-Cap Stocks Outlook for 2025 On December 24, Global Advisors’ […]
  Jan 8, 2025 - $APLT
• Here’s Why Applied Therapeutics, Inc. (NASDAQ:APLT) Is Among the Best Diabetes Stocks to Buy Under $10
  We recently compiled a list of the 10 Best Diabetes Stocks To Buy Under $10. In this article, we are going to take a look at where Applied Therapeutics, Inc. (NASDAQ:APLT) stands against the other diabetes stocks. Global Growth and Innovation in Diabetes Care: The Rise of Continuous Glucose Monitors and AI Integration About 422 million […]
  Jan 6, 2025 - $APLT
• Applied Therapeutics Appoints John H. Johnson as Executive Chairman
  Shoshana Shendelman Steps Down as CEO; Les Funtleyder Appointed Interim Chief Executive Officer Announces Business Updates NEW YORK, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a biopharmaceutical company dedicated to creating transformative treatments for rare disease, today announced the following leadership changes, effective immediately: John H. Johnson, a recognized leader in the pharmaceutical and biotechnology industry, has been named Executive Chairman;Dr
  Dec 20, 2024 - $APLT